{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:23:28Z","timestamp":1791059008124,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":7042,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1046\/j.1538-7836.2003.00349.x","type":"journal-article","created":{"date-parts":[[2003,8,28]],"date-time":"2003-08-28T04:28:29Z","timestamp":1062044909000},"page":"2022-2030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity"],"prefix":"10.1016","volume":"1","author":[{"given":"S.","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.M.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0010","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0015","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1056\/NEJM199805213382103","article-title":"A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0020","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0030","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/S0140-6736(00)03400-0","article-title":"Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial","volume":"356","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(02)07442-1","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials","volume":"359","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0040","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(00)05060-1","article-title":"Effect of glycoprotein IIb\/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.284.12.1549","article-title":"Current role of platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes","volume":"284","author":"Bhatt","year":"2000","journal-title":"JAMA"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(98)11086-3","article-title":"Platelet GP IIb-IIIa blockers","volume":"353","author":"Topol","year":"1999","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0055","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1161\/01.ATV.17.3.528","article-title":"7E3 monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa cross-reacts with the leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1","volume":"17","author":"Simon","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.98.11.1085","article-title":"Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb\/IIIa and alpha (v) beta3 integrins","volume":"98","author":"Tam","year":"1998","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0065","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","author":"Topol","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(02)09605-8","article-title":"Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study","volume":"360","author":"Moliterno","year":"2002","journal-title":"Lancet"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0075","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1083\/jcb.143.7.2081","article-title":"Activation of \u03b1v\u03b23 on vascular cells controls recognition of prothrombin","volume":"143","author":"Byzova","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/hc3101.092199","article-title":"Eptifibatide and 7E3, but not tirofiban, inhibit \u03b1v\u03b23 integrin-mediated binding of smooth muscle cells to thrombospondin and prothrombin","volume":"104","author":"Lele","year":"2001","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0085","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0021-9258(18)54042-4","article-title":"Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa","volume":"268","author":"Scarborough","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0021-9290(77)90006-9","article-title":"Analysis of pulsatile viscous blood flow through diseased coronary arteries of man","volume":"10","author":"Back","year":"1977","journal-title":"J Biomech"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0095","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1172\/JCI973","article-title":"Distinct mechanisms of platelet aggregation as a consequence of different shearing flow condition","volume":"101","author":"Goto","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0100","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI115124","article-title":"The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress","volume":"87","author":"Ikeda","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0105","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1161\/01.CIR.86.6.1859","article-title":"Epinephrine augments von Willebrand factor dependent shear-induced platelet aggregation","volume":"86","author":"Goto","year":"1992","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0110","doi-asserted-by":"crossref","first-page":"23352","DOI":"10.1074\/jbc.270.40.23352","article-title":"Characterization of the unique mechanism mediating the shear-dependent binding of soluble von Willebrand factor to platelets","volume":"270","author":"Goto","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0115","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate\u2013receptor interactions in platelet thrombus formation under flow","volume":"94","author":"Savage","year":"1998","journal-title":"Cell"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0120","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1182\/blood.V88.9.3456.bloodjournal8893456","article-title":"High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles","volume":"88","author":"Miyazaki","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0125","doi-asserted-by":"crossref","first-page":"17049","DOI":"10.1016\/S0021-9258(18)71457-9","article-title":"Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity","volume":"264","author":"Sims","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0130","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/01.CIR.0000016703.93845.AF","article-title":"Functional significance of adenosine 5\u2032-diphosphate receptor (P2Y12) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conception of high shear rate","volume":"105","author":"Goto","year":"2002","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0135","first-page":"147","article-title":"Platelet surface P-selectin molecules increased after exposing platelet to a high shear flow","volume":"19","author":"Goto","year":"2000","journal-title":"Int Angiol"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.1965.tb06586.x","article-title":"The kaolin clotting time of platelet rich plasma","volume":"11","author":"Hardisty","year":"1965","journal-title":"Br J Hematol"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0145","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1016\/S0021-9258(18)67128-5","article-title":"The von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Characterization by monoclonal antibodies and partial amino acid sequence analysis of proteolytic fragments","volume":"261","author":"Handa","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1182\/blood.V70.2.475.475","article-title":"Increased surface expression of the membrane glycoprotein IIb\/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation","volume":"70","author":"Niiya","year":"1987","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-0038-1651640","article-title":"Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation","volume":"69","author":"Ikeda","year":"1993","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood.V77.1.113.113","article-title":"Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib","volume":"77","author":"Fujimura","year":"1991","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0165","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/S0021-9258(19)84912-8","article-title":"Isolation and characterization of a platelet membrane protein related to the vitronectin receptor","volume":"264","author":"Lam","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0170","doi-asserted-by":"crossref","first-page":"24302","DOI":"10.1016\/S0021-9258(18)54228-9","article-title":"Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles","volume":"266","author":"Thiagarajan","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0175","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0049-3848(00)00192-4","article-title":"Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism","volume":"98","author":"Weber","year":"2000","journal-title":"Thromb Res"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0180","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.V95.4.1317.004k30_1317_1323","article-title":"Leukocyte\u2013leukocyte interactions mediated by platelet microparticles under flow","volume":"95","author":"Forlow","year":"2000","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1172\/JCI118859","article-title":"Inhibition of platelet-mediated tissue factor-induced thrombin generation by the mouse\/human chimeric 7E3 antibody","volume":"98","author":"Reverter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0190","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-0037-1614050","article-title":"GPIIb-IIIa antagonist-induced reduction in platelet surface factor V\/Va binding and phosphatidylserine expression in whole blood","volume":"84","author":"Furman","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0195","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood.V97.8.2314","article-title":"Antiplatelet agents in tissue factor-induced blood coagulation","volume":"97","author":"Butenas","year":"2001","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0200","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1161\/01.CIR.99.5.608","article-title":"Enhanced shear-induced platelet aggregation in acute myocardial infarction","volume":"99","author":"Goto","year":"1999","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0205","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1182\/blood-2002-02-0514","article-title":"Sequential cytoplasmic calcium signals in a two-stage platelet activation process induced by the glycoprotein Ib mechanoreceptor","volume":"100","author":"Mazzucato","year":"2002","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/blood.V94.1.172.413k17_172_178","article-title":"Contribution of distinct adhesive interactions to platelet aggregation in flowing blood","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1055\/s-0037-1615618","article-title":"Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb\/IIIa antagonists abciximab, eptifibatide and tirofiban","volume":"85","author":"Marciniak","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1097-4652(199609)168:3<521::AID-JCP4>3.0.CO;2-R","article-title":"Divalent cations regulate the organization of integrins alpha v beta 3 and alpha v beta 5 on the cell surface","volume":"168","author":"Stuiver","year":"1996","journal-title":"J Cell Physiol"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0225","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.biophys.31.101101.140922","article-title":"Conformational regulation of integrin structure and function","volume":"31","author":"Shimaoka","year":"2002","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/clpt.1994.152","article-title":"Pharmacokinetics and pharmacodynamics of MK-383, a selective non-peptide platelet glycoprotein-IIb\/IIIa receptor antagonist, in healthy men","volume":"56","author":"Barrett","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0235","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/hc2901.093504","article-title":"Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention","volume":"104","author":"Gilchrist","year":"2001","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0240","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/01.CIR.90.4.1757","article-title":"Pharmacodynamics of chimeric glycoprotein IIb\/IIIa integrin anti-platelet antibody Fab 7E3 in high-risk coronary angioplasty","volume":"90","author":"Tcheng","year":"1994","journal-title":"Circulation"},{"key":"10.1046\/j.1538-7836.2003.00349.x_bb0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2141.2001.02721.x","article-title":"Greater inhibition of platelet procoagulant activity by antibody-derived glycoprotein IIb-IIIa inhibitors than by peptide and peptidomimetic inhibitors","volume":"113","author":"Lages","year":"2001","journal-title":"Br J Haematol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1538-7836.2003.00349.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622153328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622153328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1538-7836.2003.00349.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:25:46Z","timestamp":1761531946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622153328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["S1538783622153328"],"URL":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00349.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2003,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different effects of various anti-GPIIb-IIIa agents on shear-induced platelet activation and expression of procoagulant activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00349.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}